«Using Big Blue’s machine learning algorithms to analyze data gathered from patients over as many as seven years, the programs were able to spot patterns in their symptoms linked with neurodegeneration.».

«The trove of data was collected from the Michael J. Fox Foundation’s Parkinson’s Progression Markers Initiative, a clinical study first launched in 2010 in partnership with more than 30 biotech, pharmaceutical, non-profit and private companies.»

Article written by Conor Hale. Photo by Getty Images.



Fierce Biotech